Scholarly Works - Conferences
Conference
Journal of Clinical Oncology
·
June 1, 2024
1096Background: Immune checkpoint inhibitors (ICIs) have revolutionized the treatment triple negative breast cancer (TNBC). However, not all patients with TNBC benefit from the addition of ICIs due to factors such as intrinsic and acquired resistance to IC ...
Full text
Cite
Conference
Journal of Clinical Oncology
·
January 1, 2024
Background: Immune checkpoint inhibitors (ICIs) are a therapeutic option for patients with triple-negative breast cancer (TNBC), however resistance and non-response remain an unmet clinical need. Human leukocyte antigens (HLAs) play an important role in in ...
Full text
Cite
Conference
Journal of Clinical Oncology
·
January 1, 2024
Background: Microsatellite instability (MSI) occurs via defects in mismatch repair (MMR) and is characterized by high tumor mutational burden (TMB) and a robust inflammatory response. Accurate MSI-high classification of immune-evasive tumors is vital due t ...
Full text
Cite
Conference
Cancer Causes Control
·
February 2023
PURPOSE: Clinical trials advance the standard of care for patients. Patients enrolled in trials should represent the population who would benefit from the intervention in clinical practice. The aim of this study was to assess whether clinical trials enroll ...
Full text
Link to item
Cite
Conference
Ajog Global Reports
·
November 1, 2022
BACKGROUND: Telemedicine uses technology to deliver medical care remotely and has been shown to provide similar patient satisfaction and care outcomes compared with in-person visits. OBJECTIVE: This study aimed to assess the gynecologic oncology patient te ...
Full text
Cite
